Security key
640671400
NEPHROS INC - Common Stock - $0.001 par value (NEPH)
CUSIP: 640671400
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock - $0.001 par value
- Shares outstanding
- 10,630,964
- Total 13F shares
- 4,852,312
- Share change
- +187,636
- Total reported value
- $19,846,026
- Price per share
- $4.09
- Number of holders
- 20
- Value change
- +$767,466
- Number of buys
- 11
- Number of sells
- 6
Report period
Q2 2025
Institutions
20
Top holders
10
NEPH full security history
Newer quarter: Q3 2025
Previous quarter: Q1 2025
NEPHROS INC SEC filings
NEPHROS INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 640671400
Recent filing periods:
Top shareholders of NEPH - NEPHROS INC - Common Stock - $0.001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| WEXFORD CAPITAL LP |
3/4/5
13F
|
10%+ Owner · Company |
34%
from 13F
|
3,600,552
|
$8,810,910 | — | 13 Mar 2024 | |
| Topline Capital Management, LLC |
13F
|
Company |
4%
|
422,089
|
$725,993 | — | 31 Mar 2025 | |
| Daron Evans |
3/4/5
|
CEO Specialty Renal Products |
—
mixed-class rows
|
179,718
mixed-class rows
|
$351,795 | — | 24 May 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.9%
|
204,158
|
$351,152 | — | 31 Mar 2025 | |
| BARD ASSOCIATES INC |
13F
|
Company |
1.3%
|
143,221
|
$246,341 | — | 31 Mar 2025 | |
| Andrew Astor Power |
3/4/5
|
President, CEO & CFO, Director |
—
mixed-class rows
|
131,385
mixed-class rows
|
$204,342 | — | 05 Mar 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.85%
|
90,289
|
$155,335 | — | 31 Mar 2025 | |
| Alisa Lask |
3/4/5
|
Director |
—
mixed-class rows
|
55,679
mixed-class rows
|
$109,167 | — | 01 Jan 2025 | |
| HighTower Advisors, LLC |
13F
|
Company |
0.52%
|
55,710
|
$95,821 | — | 31 Mar 2025 | |
| Tom Gwydir Power |
3/4/5
|
Director |
—
mixed-class rows
|
50,306
mixed-class rows
|
$95,210 | — | 05 Jan 2023 | |
| Wesley S. Lobo |
3/4/5
|
Chief Marketing Officer |
—
mixed-class rows
|
206,714
mixed-class rows
|
$77,461 | — | 16 Feb 2022 | |
| ELKHORN PARTNERS LIMITED PARTNERSHIP |
13F
|
Company |
0.37%
|
38,924
|
$67,000 | — | 31 Mar 2025 | |
| BLAIR WILLIAM & CO/IL |
13F
|
Company |
0.34%
|
36,249
|
$62,348 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.22%
|
23,618
|
$40,623 | — | 31 Mar 2025 | |
| Joseph Michael Harris |
3/4/5
|
Director |
—
mixed-class rows
|
24,743
mixed-class rows
|
$39,719 | — | 01 Jan 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.15%
|
15,698
|
$27,001 | — | 31 Mar 2025 | |
| Mesirow Financial Investment Management, Inc. |
13F
|
Company |
0.13%
|
13,800
|
$23,736 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.11%
|
12,024
|
$20,681 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.05%
|
5,423
|
$9,328 | — | 31 Mar 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.03%
|
2,798
|
$4,813 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
79
|
$136 | — | 31 Mar 2025 | |
| JONES FINANCIAL COMPANIES LLLP |
13F
|
Company |
0%
|
31
|
$52 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
13
|
$22 | — | 31 Mar 2025 |
Institutional Holders of NEPHROS INC - Common Stock - $0.001 par value (NEPH) as of Q2 2025
As of 30 Jun 2025,
NEPHROS INC - Common Stock - $0.001 par value (NEPH) was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,852,312 shares.
The largest 10 holders included
WEXFORD CAPITAL LP, Topline Capital Management, LLC, VANGUARD GROUP INC, BARD ASSOCIATES INC, GEODE CAPITAL MANAGEMENT, LLC, HighTower Advisors, LLC, BLAIR WILLIAM & CO/IL, SUSQUEHANNA INTERNATIONAL GROUP, LLP, ESSEX INVESTMENT MANAGEMENT CO LLC, and STATE STREET CORP.
This page lists
20
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
17
Q2 2025 holders
20
Holder diff
3
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.